Rigel Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Rigel Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Rigel Pharmaceuticals Inc Strategy Report
- Understand Rigel Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Rigel Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
22 Feb 2024 | Rigel Pharma to Acquire U.S. Rights to GAVRETO from Blueprint Medicines for USD15 Million | Asset Transaction |
Rigel Pharmaceuticals Inc
|
Blueprint Medicines Corp |
08 Dec 2023 | Rigel Pharma Enters into Agreement with University of Texas MD Anderson Cancer Center | Partnership | - |
Rigel Pharmaceuticals Inc
University of Texas MD Anderson Cancer Center
|
02 Aug 2022 | Rigel Pharma Enters into Licensing Agreement with Forma Therapeutics | Licensing Agreement |
Rigel Pharmaceuticals Inc
|
Forma Therapeutics Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer